Phase I clinical trial shows treatment design
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
New biomarker tests identified NASH and related conditions at least as well as common lab tests, paving the way for blood-based alternatives to liver biopsy for clinical care and therapeutic trials.
When COVID-19 presented the world with the greatest health challenge in modern history, it was biomedical scientists who stepped up to develop diagnostic testing and vaccines to slow the spread of the disease.But how did these in-demand scientists fa
KENNEDY SPACE CENTER (FL), Sept. 5, 2023 – Four astronauts ended a six-month science expedition onboard the International Space Station (ISS) with the successful splashdown of the SpaceX Dragon Endeavour spacecraft off the coast of Florida early Monday morning. During their time in space, the crew members worked on dozens of research investigations and technology demonstration projects that were sponsored by…